JAK2 mutation is a genetic alteration in the Janus kinase 2 gene, commonly associated with myeloproliferative neoplasms, which are blood cancers characterized by the overproduction of blood cells. This mutation leads to constitutive activation of the JAK-STAT signaling pathway, promoting uncontrolled cell proliferation and survival.